| Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes | 2019/10/01 | | 193 |
| NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines | 2007/05/01 | | 191 |
| Acute Myeloid Leukemia | 2012/08/01 | English | 187 |
| Short Screening Tools for Cancer-Related Distress: A Review and Diagnostic Validity Meta-Analysis | 2010/04/01 | | 186 |
| Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology | 2018/01/01 | English | 185 |
| Guidelines Insights: Hepatobiliary Cancers, Version 2.2019 | 2019/04/01 | | 184 |
| NCCN Guidelines Insights: Bone Cancer, Version 2.2017 | 2017/02/01 | English | 178 |
| Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology | 2022/10/01 | | 175 |
| NCCN Guidelines® Insights: Breast Cancer, Version 4.2021 | 2021/05/01 | | 172 |
| NCCN Guidelines Insights: Cervical Cancer, Version 1.2020 | 2020/06/01 | | 171 |
| NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology | 2011/11/01 | | 169 |
| Lung Cancer Screening | 2012/02/01 | English | 169 |
| Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology | 2018/06/01 | English | 168 |
| NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019 | 2019/08/01 | | 168 |
| Kidney Cancer, Version 3.2015 | 2015/02/01 | English | 168 |
| NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 | 2019/09/01 | | 167 |
| Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines | 2012/09/01 | English | 164 |
| Cancer-Related Fatigue | 2010/08/01 | English | 163 |
| Risk and Timing of Neutropenic Events in Adult Cancer Patients Receiving Chemotherapy: The Results of a Prospective Nationwide Study of Oncology Practice | 2008/02/01 | | 162 |
| NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021 | 2020/12/01 | | 162 |
| Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology | 2017/10/01 | English | 160 |
| Non-Hodgkin’s Lymphomas | 2010/03/01 | | 159 |
| Colon Cancer, Version 3.2014 | 2014/07/01 | English | 159 |
| Head and Neck Cancers, Version 2.2014 | 2014/10/01 | English | 159 |
| NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022 | 2022/03/01 | | 158 |
| Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology | 2016/05/01 | English | 156 |
| Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring aPOLEMutation | 2017/02/01 | English | 156 |
| Thyroid Carcinoma | 2010/11/01 | | 155 |
| NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021 | 2021/01/06 | | 155 |
| NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018 | 2018/10/01 | English | 154 |